Omalizumab Retreatment of Patients swith Chronic Idopathic Urticaria/Spontaneous Urticaria (CIU/CSU) Following Return of Symptoms: Primary Results of the OPTIMA Study. J of Skin. 2017;1(3.1):s127. doi:10.25251/skin.1.supp.126